Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
An early-phase antibody therapy was tested in patients with relapsed or refractory Non-Hodgkin lymphoma and Chronic lymphocytic leukemia; th…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating fludarabine in combination with alemtuzumab or rituximab in patients with refractory or relapsed B-cell ch…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 2]
This Phase 2 trial evaluated adding rituximab to combination chemotherapy in patients with previously treated chronic lymphocytic leukemia; …
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia [Phase 2]
A phase 2 trial evaluating fludarabine with alemtuzumab or cyclophosphamide, followed by peripheral blood stem cell transplantation or alemt…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP [Phase 3]
A Phase 3 trial in chronic lymphocytic leukemia comparing Fludarabine, Cyclophosphamide, and Rituximab versus Alemtuzumab has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) [Phase 1]
Phase 1 clinical trial update for niraparib (MK-4827) in participants with advanced solid tumors or hematologic malignancies, sponsored by T…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders [Phase 1, Phase 2]
Phase 1/2 trial of VNP40101M for Richter syndrome and refractory/relapsed chronic lymphocytic leukemia or other lymphoproliferative disorder…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents [Phase 2]
GlaxoSmithKline's agent 506U78 completed a Phase 2 trial in Chronic Lymphocytic Leukemia patients who failed fludarabine or alkylating thera…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating Apolizumab in patients with relapsed or refractory chronic lymph…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluated the combination of epirubicin and rituximab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma or…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [Phase 3]
This Phase 3 trial evaluated epoetin alfa for treating anemia in patients with lymphoma, chronic lymphocytic leukemia, or multiple myeloma w…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 trial evaluating alvocidib (flavopiridol) for chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) [Phase 4]
This Phase 4 clinical trial update evaluates the safety and efficacy of busulfan as a conditioning regimen prior to hematopoietic cell trans…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial of Dolastatin 10 in patients with indolent non-Hodgkin lymphoma, Waldenström's macroglobulinemia, or chronic lymphocytic leuke…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
A completed Phase 1 study evaluating thalidomide in patients with asymptomatic indolent non-Hodgkin lymphoma or chronic lymphocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers [Phase 2]
This Phase 2 trial update reports on the use of pentostatin, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia a…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial testing Rituximab plus Beta-Glucan in chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer [Phase 1]
This clinical trial update reports the Phase 1 safety and tolerability results of PCI-24781 in cancer patients. The study, sponsored by Phar…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 safety study of GCS-100 in patients with chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]
This is a completed Phase 1 study of Navitoclax (ABT-263) in combination with either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial of thalidomide with or without fludarabine in patients with small lymphocytic lymphoma and chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia [Phase 1]
A Phase 1 trial of tanespimycin (17-N-allylamino-17-demethoxygeldanamycin) with or without rituximab in relapsed B-cell chronic lymphocytic …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of a monoclonal antibody therapy in patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, acute lym…